Lord, Abbett & Co
KRTX

Lord, Abbett & Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Lord, Abbett & Co’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-139,618
Closed -$23.6M – 603
2023
Q3 		$23.6M Sell
139,618
-434,988
-76% -$81.8M 0.09% 300
2023
Q2 		$125M Buy
574,606
+83,464
+17% +$17.9M 0.43% 56
2023
Q1 		$89.2M Sell
491,142
-57,179
-10% -$10.9M 0.32% 88
2022
Q4 		$108M Sell
548,321
-146,457
-21% -$31.4M 0.39% 69
2022
Q3 		$156M Buy
694,778
+412,548
+146% +$83.5M 0.57% 39
2022
Q2 		$35.7M Sell
282,230
-87,315
-24% -$10M 0.13% 222
2022
Q1 		$46.9M Buy
369,545
+127,840
+53% +$14.4M 0.12% 231
2021
Q4 		$31.7M Sell
241,705
-69,911
-22% -$9.04M 0.07% 329
2021
Q3 		$38.1M Sell
311,616
-57,030
-15% -$6.58M 0.09% 323
2021
Q2 		$42M Buy
368,646
+55,085
+18% +$6.44M 0.1% 287
2021
Q1 		$37.7M Buy
313,561
+37,834
+14% +$4.29M 0.1% 310
2020
Q4 		$28M Buy
275,727
+6,648
+2% +$616K 0.07% 360
2020
Q3 		$20.8M Buy
269,079
+7,535
+3% +$642K 0.07% 372
2020
Q2 		$29.2M Sell
261,544
-52,031
-17% -$4.52M 0.1% 305
2020
Q1 		$22.6M Buy
313,575
+120,612
+63% +$10.3M 0.1% 302
2019
Q4 		$14.5M Buy
+192,963
New +$8.45M 0.05% 451

Other funds holding KRTX

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Lord, Abbett & Co's KRTX Position: Q4 2023 in Review

Lord, Abbett & Co sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 139,618 shares — an estimated $23.6M sold.

Lord, Abbett & Co first reported a position in KRTX in Q4 2019 and held it in 16 quarters. The position peaked at $156M in Q3 2022. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Lord, Abbett & Co reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 139,618 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $23.6M.
  • Lord, Abbett & Co first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Lord, Abbett & Co's Karuna Therapeutics, Inc. Common Stock position peaked at $156M in Q3 2022.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Lord, Abbett & Co's 13F filing for Q4 2023, filed 12 Feb 2024.